Cleared Abbreviated

K983861: DISTAFLO BYPASS GRAFT

K983861 · Impra, Inc. · Cardiovascular
Nov 1998
Decision
22d
Days
Class 2
Risk

K983861 is an FDA 510(k) clearance for the DISTAFLO BYPASS GRAFT, a Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (Class II — Special Controls, product code DSY), submitted by Impra, Inc. (Tempe, US). The FDA issued a Cleared decision on November 24, 1998, 22 days after receiving the submission on November 2, 1998. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.3450.

Submission Details

510(k) Number K983861 FDA.gov
FDA Decision Cleared SESE
Date Received November 02, 1998
Decision Date November 24, 1998
Days to Decision 22 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DSY — Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
Device Class Class II — Special Controls
CFR Regulation 21 CFR 870.3450

Similar Devices — DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

All 186
Spiral Laminar Flow? Vascular Arteriovenous Graft (AV0645)
K252277 · Vascular Flow Technologies Limited · Oct 2025
Gelweave? Vascular Prostheses
K241550 · Vascutek, Ltd. · Feb 2025
Gelsoft? Plus Vascular Prostheses
K241070 · Vascutek, Ltd. · Nov 2024
Advanta VXT Vascular Graft, Flixene Vascular Graft
K231972 · Atrium Medical Corporation · Mar 2024
GORE? PROPATEN? Vascular Graft
K240083 · W.L. Gore & Associates, Inc. · Mar 2024
exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts
K233783 · Peca Labs, Inc. · Jan 2024